Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, marketed as Mounjaro for diabetes, has become widely recognized for its powerful weight loss effects in clinical practice. A landmark trial published in the New England Journal of Medicine demonstrated that patients receiving tirzepatide lost significantly more weight than those on semaglutide alone. PlexusDx offers compounded tirzepatide injection through licensed 503A pharmacies, making personalized weight loss therapy accessible nationwide without insurance or membership fees.

What Is Tirzepatide and How Does It Work for Weight Loss?

Tirzepatide is a once-weekly injectable medication that activates two hormone pathways: the GLP-1 receptor and the GIP receptor. This dual-action approach makes it fundamentally different from semaglutide, which targets only the GLP-1 receptor. By stimulating both pathways, tirzepatide creates a more comprehensive signal to the brain's appetite control centers, leading to reduced hunger, increased feelings of fullness, and improved blood sugar regulation.

The medication slows stomach emptying, meaning food stays in your digestive system longer, creating sustained satiety between meals. Additionally, tirzepatide may enhance your body's ability to process glucose and improve insulin sensitivity. These combined mechanisms address multiple biological drivers of weight gain, which is why clinical outcomes show consistently stronger results compared to single-pathway medications.

Clinical Trial Results: Weight Loss Outcomes with Tirzepatide

The SURMOUNT trial program evaluated tirzepatide across 68 weeks in patients with obesity and overweight conditions. Participants receiving the highest dose lost an average of 22% of their starting body weight—approximately 52 pounds for someone weighing 250 pounds. By comparison, patients on semaglutide lost approximately 17% of body weight, and those on placebo lost only 3%. These results represent a meaningful advancement in medical weight loss therapy.

Importantly, weight loss was sustained throughout the trial period, with most patients maintaining their results through the end of the study. Side effects were generally mild to moderate and most commonly included nausea and vomiting, which typically decreased over time as the body adapted. The cardiovascular benefits associated with GLP-1 receptor agonists, including improvements in blood pressure and cholesterol, were also observed in tirzepatide studies.

How PlexusDx Delivers Compounded Tirzepatide

PlexusDx partners exclusively with licensed 503A compounding pharmacies to prepare tirzepatide injections tailored to individual patient needs. Unlike mass-produced medications, compounded formulations allow for precise dose customization and can be adjusted as your body responds to treatment. All compounded medications are prepared in facilities subject to rigorous quality standards and regulatory oversight by state pharmacy boards and the FDA.

Your dose may need to go up. Your price won't. PlexusDx charges a flat monthly rate of $249 for compounded tirzepatide injection, regardless of your dose level. This transparent pricing model means you never pay more if your provider increases your dose as part of your personalized weight loss plan. No insurance is required, and your monthly payment is HSA/FSA eligible, making the medication accessible to patients with various financial situations.

Is Tirzepatide Right for You? Genetics and Personalization

Not all patients respond equally to tirzepatide, and your genetic makeup plays a significant role in how well you'll respond to GLP-1 and GIP receptor stimulation. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month), which analyzes key genetic variants including GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313. These variants influence how your body processes appetite-regulating peptides and can predict which medication—tirzepatide, semaglutide, or a dual compound—will deliver the best results for your specific biology.

By mapping 14 distinct metabolic pathways and analyzing 49 key peptides, the Precision Peptide Genetic Test provides 150+ genetic insights into your weight loss potential. This data allows your PlexusDx provider to recommend not just whether tirzepatide is appropriate, but also the optimal starting dose and escalation strategy for your individual genetic profile. Personalized medicine improves adherence and outcomes, transforming weight loss from a one-size-fits-all approach into a precision-guided strategy.

Side Effects and Safety Considerations

Tirzepatide is generally well tolerated, with the most common side effects being gastrointestinal: nausea, vomiting, diarrhea, and constipation. These effects are usually mild to moderate and tend to improve as your body adjusts over the first 4–8 weeks of treatment. Staying hydrated, eating smaller meals, and following your provider's dose escalation schedule carefully help minimize digestive discomfort.

Rare but serious side effects include pancreatitis (inflammation of the pancreas) and gallbladder issues, which may require medical attention. Tirzepatide is not recommended for patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2. If you have these conditions or any concerns about your medical history, discuss them with your PlexusDx provider before starting treatment. Regular monitoring and open communication with your healthcare team ensure safe and effective therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I expect to lose with tirzepatide?

Clinical trials show average weight loss of 20–22% of body weight over 68 weeks, with most patients achieving meaningful results by 12–16 weeks. Individual results vary based on genetics, lifestyle, and adherence to the treatment plan. PlexusDx's Precision Peptide Genetic Test can help predict your likely response based on your unique peptide pathway genetics.

Is tirzepatide more effective than semaglutide for weight loss?

Yes. The SURMOUNT trial directly compared tirzepatide to semaglutide and showed tirzepatide produced approximately 5% greater weight loss (22% vs. 17%). This difference comes from tirzepatide's dual-action mechanism, which stimulates both GLP-1 and GIP receptors, whereas semaglutide targets only GLP-1. For some patients, semaglutide may still be the optimal choice depending on their genetic profile and tolerance.

How much does PlexusDx compounded tirzepatide cost?

Compounded tirzepatide injection starts at $249 per month, with a flat rate regardless of your dose level. PlexusDx serves all 50 states, requires no insurance or membership fees, and accepts HSA/FSA payments. After your first month of treatment, you can add the Precision Peptide Genetic Test for $99 to optimize your therapy.

What are the most common side effects of tirzepatide?

Nausea, vomiting, diarrhea, and constipation are the most frequently reported side effects, typically appearing in the first 1–2 weeks and improving within 4–8 weeks as your body adapts. Serious side effects are rare but may include pancreatitis or gallbladder complications. Your PlexusDx provider monitors your response and can adjust your dose schedule if needed.

Can the Precision Peptide Genetic Test tell me if tirzepatide is right for me?

Yes. The test analyzes variants in GLP1R, GIPR, MC4R, and FTO genes that directly influence your response to tirzepatide and other GLP-1 therapies. By mapping 14 metabolic pathways and 49 peptides, it provides 150+ insights into which medication and dose strategy will work best for your genetics, allowing PlexusDx providers to personalize your weight loss plan.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves